The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Lead‐Oriented Synthesis: A New Opportunity for Synthetic Chemistry
Abstract
The pharmaceutical industry remains solely reliant on synthetic chemistry methodology to prepare compounds for small‐molecule drug discovery programmes. The importance of the physicochemical properties of these molecules in determining their success in drug development is now well understood but we present here data suggesting that much synthetic methodology is unintentionally predisposed to producing molecules with poorer drug‐like properties. This bias may have ramifications to the early hit‐ and lead‐finding phases of the drug discovery process when larger numbers of compounds from array techniques are prepared. To address this issue we describe for the first time the concept of lead‐oriented synthesis and the opportunity for its adoption to increase the range and quality of molecules used to develop new medicines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
Roughley, S. D., & Jordan, A. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200187y · Cited by 2,725
Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,568
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R., Murray, C., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,354
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
Physiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 946
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
Lipophilicity in drug discovery
Waring, M. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003605098 · Cited by 873
The Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
970 Million Druglike Small Molecules for Virtual Screening in the Chemical Universe Database GDB-13
Blum, L. C., & Reymond, J.-L. (2009) · Journal of the American Chemical Society · doi:10.1021/ja902302h · Cited by 860
Protecting-group-free synthesis as an opportunity for invention
Young, I. S., & Baran, P. S. (2009) · Nature Chemistry · doi:10.1038/nchem.216 · Cited by 667
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Pursuing the leadlikeness concept in pharmaceutical research
Hann, M. M., & Oprea, T. I. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.003 · Cited by 515
Molecular Shape Diversity of Combinatorial Libraries: A Prerequisite for Broad Bioactivity
Sauer, W. H. B., & Schwarz, M. K. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci025599w · Cited by 498
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Dobson, P. D., & Kell, D. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2438 · Cited by 475
Chemical space as a source for new drugs
Reymond, J.-L., van Deursen, R., Blum, L. C., & Ruddigkeit, L. (2010) · MedChemComm · doi:10.1039/c0md00020e · Cited by 347
Covalent Modifiers: An Orthogonal Approach to Drug Design
Potashman, M. H., & Duggan, M. E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8008597 · Cited by 346
Clemons, P. A., Bodycombe, N. E., Carrinski, H. A., Wilson, J. A., Shamji, A. F., Wagner, B. K., Koehler, A. N., & Schreiber, S. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012741107 · Cited by 346
Fragment-based lead discovery: leads by design
Carr, R. A. E., Congreve, M., Murray, C. W., & Rees, D. C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03511-7 · Cited by 343
Waring, M. J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.109 · Cited by 326
Cooper, T. W. J., Campbell, I. B., & Macdonald, S. J. F. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002238 · Cited by 299
Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity
Hill, A. P., & Young, R. J. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.016 · Cited by 258
Jadhav, A., Ferreira, R. S., Klumpp, C., Mott, B. T., Austin, C. P., Inglese, J., Thomas, C. J., Maloney, D. J., Shoichet, B. K., & Simeonov, A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901070c · Cited by 238
Rebuilding the R&D engine in big pharma.
Garnier, J.-P. (2008) · PubMed · Cited by 228
Huth, J. R., Mendoza, R., Olejniczak, E. T., Johnson, R. W., Cothron, D. A., Liu, Y., Lerner, C. G., Chen, J., & Hajduk, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0455547 · Cited by 228
A quantitative assessment of hERG liability as a function of lipophilicity
Waring, M. J., & Johnstone, C. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.061 · Cited by 159
The evolution of synthetic oral drug properties
Proudfoot, J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.024 · Cited by 129
Classification of Organic Molecules by Molecular Quantum Numbers
Nguyen, K. T., Blum, L. C., van Deursen, R., & Reymond, J. (2009) · ChemMedChem · doi:10.1002/cmdc.200900317 · Cited by 120
Gleeson, M. P., Bravi, G., Modi, S. P., & Lowe, D. M. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.002 · Cited by 111
Chuprina, A., Lukin, O. V., Demoiseaux, R., Buzko, A., & Shivanyuk, A. N. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci900464s · Cited by 98
Implications of the Dominant Role of Transporters in Drug Uptake by Cells (Supplementary Material)
Dobson, P. D., Lanthaler, K., Oliver, S. G., & Kell, D. B. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609787521616 · Cited by 94
Reducing the Risk of Drug Attrition Associated with Physicochemical Properties
Leeson, P. D., & Empfield, J. R. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45024-1 · Cited by 85
Comprehensive Survey of Chemical Libraries for Drug Discovery and Chemical Biology: 2009
Dolle, R. E., Bourdonnec, B. L., Worm, K., Morales, G. A., Thomas, C. J., & Zhang, W. (2010) · Journal of Combinatorial Chemistry · doi:10.1021/cc100128w · Cited by 85
Drug prototypes and their exploitation
(1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)90084-7 · Cited by 78
Ertl, P. (2007) · Methods and principles in medicinal chemistry · doi:10.1002/9783527621286.ch5 · Cited by 75
A Simple Assay for Detection of Small-Molecule Redox Activity
Lor, L. A., Schneck, J. L., McNulty, D. E., Diaz, E., Brandt, M. A., Thrall, S. H., & Schwartz, B. K. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107304113 · Cited by 71
Rhoden, C. R. B., Rivera, D. G., Kreye, O., et al. (2009) · Journal of Combinatorial Chemistry · doi:10.1021/cc900106u · Cited by 55
Cooper, T. W. J., Campbell, I. B., & Macdonald, S. J. F. (2010) · Angewandte Chemie · doi:10.1002/ange.201002238 · Cited by 52
Transporter-mediated uptake into cellular compartments
Oswald, S., Grube, M., Siegmund, W., & Kroemer, H. K. (2007) · Xenobiotica · doi:10.1080/00498250701570251 · Cited by 49
Tosatti, P., Horn, J., Campbell, A. J., House, D., Nelson, A. S., & Marsden, S. P. (2010) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201000721 · Cited by 41
Efficient and Convenient Synthesis of Indazol-3(2H)-ones and 2-Aminobenzonitriles
Dou, G., & Shi, D. (2009) · Journal of Combinatorial Chemistry · doi:10.1021/cc9001058 · Cited by 37
Chapter 28 Fragment-Based Lead Discovery
Congreve, M., Murray, C. W., Carr, R. A. E., & Rees, D. C. (2007) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(07)42028-0 · Cited by 24
Cited by
The medicinal chemist's toolbox for late stage functionalization of drug-like molecules
Cernak, T., Dykstra, K. D., Tyagarajan, S., Vachal, P., & Krska, S. W. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00628g · Cited by 1,743
Organic synthesis provides opportunities to transform drug discovery
Blakemore, D. C., Castro, L., Churcher, I., Rees, D. C., Thomas, A. W., Wilson, D. M., & Wood, A. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0021-z · Cited by 1,485
Self-citationExpanding the medicinal chemistry synthetic toolbox
Boström, J., Brown, D. G., Young, R. J., & Keserü, G. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.116 · Cited by 665
A robustness screen for the rapid assessment of chemical reactions
Collins, K. D., & Glorius, F. (2013) · Nature Chemistry · doi:10.1038/nchem.1669 · Cited by 625
Nanomole-scale high-throughput chemistry for the synthesis of complex molecules
Buitrago Santanilla, A., Regalado, E. L., Pereira, T., Shevlin, M., Bateman, K., Campeau, L.-C., Schneeweis, J., Berritt, S., Shi, Z.-C., Nantermet, P., et al. (2015) · Science · doi:10.1126/science.1259203 · Cited by 603
Metadata
- Authors
- Nadin, A., Hattotuwagama, C., & Churcher, I.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2012-01-03
- Volume
- 51
- Issue
- 5
- Pages
- 1114-1122
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W1975237431
- Cited by
- 390
- References
- 49
- FWCI
- 36.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.